Orf Virus in Goats and Sheep: Veterinary Reference

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-05-25

Key Takeaways

• Orf virus (ORFV) is the causative agent of contagious ecthyma (CE) in goats and sheep, characterized by proliferative, pustular, and scabby lesions on mucocutaneous junctions and the coronary band.
• Transmission occurs primarily through direct contact with infected animals or contaminated fomites, with the virus demonstrating remarkable environmental stability, retaining infectivity for decades under refrigeration.
• Diagnosis relies on a combination of clinical signs, histopathology, and molecular detection methods such as real-time PCR targeting the B2L gene, with serological assays like indirect ELISAs also used for surveillance.
• ORFV employs sophisticated immune evasion strategies, including inhibition of interferon-γ signaling via STAT1 dephosphorylation and complement evasion, contributing to persistent infections and reinfection potential.
• Control measures involve strict biosecurity, isolation, disinfection, and vaccination with live attenuated vaccines, though cross-protection against heterologous strains is limited; novel vaccine candidates are being developed through gene deletion strategies.
• Differential diagnosis is critical to distinguish ORFV from other vesicular or proliferative diseases in small ruminants, such as foot-and-mouth disease, bluetongue, and sheeppox, necessitating a structured diagnostic workflow.

Introduction

Orf virus (ORFV) is the prototypical member of the genus Parapoxvirus within the family Poxviridae and is the etiological agent of contagious ecthyma (CE), also known as contagious pustular dermatitis, in small ruminants. The disease is characterized by proliferative, pustular, and scabby lesions on the lips, nostrils, oral mucosa, udder, and coronary band of goats and sheep [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. ORFV is epitheliotropic and causes localized cutaneous infections that typically resolve within four to six weeks, although severe and persistent cases occur, particularly in young or immunocompromised animals [<a href="#ref-1">1</a>]. The virus possesses a double-stranded DNA genome of approximately 130 to 140 kilobase pairs (kbp) with terminal inverted repeats and a high GC content (approximately 64%) [<a href="#ref-3">3</a>]. This article provides an exhaustive veterinary reference on ORFV in goats and sheep, integrating recent genomic, immunological, and diagnostic advances.

Virology and Genomic Organization

ORFV shares the typical poxvirus morphology: ovoid virions measuring 260 by 160 nm with a criss‑cross tubular surface pattern [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The genome encodes approximately 130 open reading frames (ORFs), with a central conserved core region flanked by variable termini that contain genes involved in host range, virulence, and immune modulation [<a href="#ref-3">3</a>]. Key structural proteins include the major envelope protein B2L (a homolog of vaccinia virus F13L) and the F1L protein, both of which are used as diagnostic antigens [<a href="#ref-4">4</a>, <a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. The A32L ATPase protein is another conserved target for molecular detection [<a href="#ref-6">6</a>]. The scaffolding protein ORFV075 has been resolved by cryo‑electron microscopy, revealing a structure that facilitates virion assembly [<a href="#ref-8">8</a>]. Whole‑genome analyses of isolates from Europe, South America, Africa, and Asia demonstrate substantial genetic diversity driven by recombination and positive selection [<a href="#ref-3">3</a>, <a href="#ref-9">9</a>, <a href="#ref-10">10</a>].

Global Epidemiology and Host Range

ORFV circulates endemically in sheep and goat populations worldwide, with seroprevalence exceeding 80% in some regions [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. The virus infects both domestic and wild Caprinae, including Iberian ibex (Capra pyrenaica) [<a href="#ref-13">13</a>]. Outbreaks are frequently reported in Africa, the Middle East, Asia, and South America [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. In Nigeria, concurrent infection of goats with ORFV and bovine herpesvirus 1 has been documented, highlighting the potential for viral co‑infections. Transmission occurs through direct contact with infected animals or contaminated fomites; the virus is exceptionally stable in the environment, retaining infectivity for at least 35 years under refrigeration [<a href="#ref-17">17</a>]. Mechanical vectors such as the common house fly (Musca domestica) can carry ORFV DNA, although their role in transmission is not fully quantified.

Pathogenesis and Clinical Manifestations

ORFV infection begins with viral entry into keratinocytes via host factors including KCNE4, a potassium channel subunit that mediates viral attachment and entry [<a href="#ref-18">18</a>]. The virus replicates in the epidermis, inducing pronounced hyperplasia and angiogenesis, leading to the formation of papillomatous lesions that progress through papular, vesicular, pustular, and scab stages [<a href="#ref-1">1</a>]. Histologically, lesions show acanthosis, ballooning degeneration of keratinocytes, and intracytoplasmic eosinophilic inclusion bodies [<a href="#ref-19">19</a>]. A recent study using multi‑omics approaches in primary ovine fetal turbinate cells revealed that ORFV reprograms host metabolism, particularly amino acid and lipid pathways, to support viral replication [<a href="#ref-20">20</a>].

Clinical signs in goats and sheep include proliferative scabs and crusts on the lips and muzzle, often extending to the nostrils, eyelids, and udder [<a href="#ref-1">1</a>]. In severe cases, lesions become hemorrhagic and prone to secondary bacterial infections, which can lead to mastitis, pneumonia, or septicemia [<a href="#ref-1">1</a>, <a href="#ref-21">21</a>]. A study from Tanzania molecularly confirmed ORFV in goats with typical clinical signs across four districts [<a href="#ref-14">14</a>]. In Lao goats, proliferative lip and facial lesions were causally linked to ORFV infection [<a href="#ref-11">11</a>]. Vertical transmission of ORFV has been demonstrated in goats, with virus detected in fetal tissues and placenta, suggesting transplacental infection, and a prevention strategy using vaccination of pregnant does has been proposed [<a href="#ref-22">22</a>]. Vertical transmission was also confirmed in a mouse model, further supporting the possibility of congenital infection [<a href="#ref-23">23</a>].

Immune Evasion and Host Interactions

ORFV employs a multifaceted strategy to subvert host immune responses. The virus encodes a phosphatase, OH1, which interacts with and dephosphorylates signal transducer and activator of transcription 1 (STAT1), thereby inhibiting interferon‑γ signaling [<a href="#ref-24">24</a>]. The ORFV129 protein binds to host complement C1q binding protein, reducing complement‑mediated neutralization [<a href="#ref-25">25</a>]. Additionally, ORFV induces complete autophagy in infected cells by inhibiting the AKT/mTOR pathway and activating the ERK1/2/mTOR signaling cascade, a process that promotes viral replication. Antibody‑dependent enhancement (ADE) of ORFV uptake has been observed; sub‑neutralizing antibodies can facilitate viral entry into Fc receptor‑bearing cells, potentially exacerbating infection [<a href="#ref-26">26</a>]. The virus also downregulates innate immune sensing via suppression of pattern recognition receptor pathways [<a href="#ref-27">27</a>].

Diagnostics

Accurate and rapid diagnosis of ORFV is essential for outbreak management and differentiation from other vesicular diseases such as foot‑and‑mouth disease, bluetongue, and sheeppox [<a href="#ref-11">11</a>, <a href="#ref-28">28</a>, <a href="#ref-29">29</a>]. A combination of clinical examination, histopathology, molecular assays, and serology is recommended.

Molecular Detection

Real‑time polymerase chain reaction (qPCR) targeting the B2L gene is widely used [<a href="#ref-28">28</a>, <a href="#ref-30">30</a>]. A duplex TaqMan qPCR assay enabling simultaneous detection of ORFV and Brucella spp. in goats has been developed, facilitating co‑infection screening [<a href="#ref-30">30</a>]. A freeze‑dried real‑time PCR assay for 11 sheep and goat pathogens, including ORFV, offers multiplexed detection with high throughput [<a href="#ref-28">28</a>]. Isothermal amplification methods such as loop‑mediated isothermal amplification (LAMP) and recombinase‑aided amplification (RAA) provide rapid, field‑deployable alternatives. A visual closed‑tube LAMP assay for ORFV detection in sheep and goats has been validated. Conventional PCR and sequencing of the B2L or A32L genes remain standard for phylogenetic characterization [<a href="#ref-6">6</a>, <a href="#ref-31">31</a>, <a href="#ref-32">32</a>].

Serological Assays

Indirect enzyme‑linked immunosorbent assays (ELISAs) based on recombinant ORFV114, B2L, or F1L antigens have been developed for serodiagnosis in goats [<a href="#ref-7">7</a>, <a href="#ref-33">33</a>]. These assays exhibit high sensitivity and specificity and are suitable for serosurveillance [<a href="#ref-33">33</a>].

Differential Diagnosis

ORFV infection must be differentiated from other causes of proliferative or vesicular lesions in small ruminants. The following table summarizes key differential diagnoses:

Diagnostic Workflow

The following decision tree outlines a recommended diagnostic approach:

flowchart TD
 A["Clinical suspicion of Orf"] --> B{"Lesion type"}
 B -->|"Proliferative scabs"| C["Collect swab/scab in viral transport medium"]
 B -->|"Vesicular/exudative"| D["Collect vesicular fluid + swab"]
 C --> E["DNA extraction"]
 D --> E
 E --> F["Real-time PCR targeting B2L gene"]
 F --> G{"Result"}
 G -->|"Positive"| H["Confirm ORFV infection"]
 G -->|"Negative"| I["Perform differential PCR panel for FMDV, BTV, capripox"]
 I --> J{"Result"}
 J -->|"Other pathogen identified"| K["Diagnose accordingly"]
 J -->|"No pathogen"| L["Consider serology / histopathology"]
 H --> M["Report to veterinary authority"]
 K --> M

Transmission and Environmental Persistence

ORFV is shed in high titers from scab material and exudates. The virus has been detected in the saliva and milk of dairy goats, indicating potential for lactogenic and direct contact transmission. Mechanical vectors such as house flies can transport ORFV DNA to skin abrasions. Environmental stability is remarkable; ORFV remained infectious after 35 years of refrigeration [<a href="#ref-17">17</a>]. This persistence complicates eradication and leads to recurrent outbreaks on farms.

Control and Vaccination

Control measures include strict biosecurity, isolation of infected animals, disinfection of contaminated facilities, and vaccination. Live attenuated vaccines are available but carry limited cross‑protection against heterologous strains [<a href="#ref-29">29</a>]. Recent vaccine development efforts have focused on rationally attenuated strains. Deletion of virulence genes such as OV132, OV112, and ORFV129 yields attenuated mutants that retain immunogenicity in goats. A quadruple gene‑deleted ORFV strain has been constructed as a vaccine candidate [<a href="#ref-34">34</a>]. A triple‑gene deletion mutant showed safety and efficacy in target species [<a href="#ref-35">35</a>]. A DNA prime‑protein boost strategy induced superior immune responses compared to adenovirus‑based vaccination in mice and sheep. Vaccination of pregnant goats reduced vertical transmission of ORFV, supporting its use in endemic flocks [<a href="#ref-22">22</a>]. However, challenges remain due to the virus’s ability to reinfect previously exposed animals because of its immune evasion mechanisms [<a href="#ref-27">27</a>].

Conclusion

Orf virus is a globally important pathogen of goats and sheep, causing substantial economic losses through morbidity, secondary infections, and trade restrictions. Recent advances in genomics, immune evasion biology, and molecular diagnostics have improved our understanding of ORFV epidemiology and pathogenesis. The development of next‑generation vaccines and field‑deployable diagnostic tools will enhance control strategies. Continued research into host‑pathogen interactions, particularly the mechanisms of vertical transmission and antibody‑dependent enhancement, is essential for designing effective interventions.

Related Clinical & Scientific Guides

• Ferret Influenza Virus
• Turkey Adenovirus 3
• Avian Paramyxovirus 3

References